| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 107, 1405-1409, Copyright © 1980 by Endocrine Society
ARTICLES |
DR Sibley and I Creese
[3H]Spiroperidol ([3H]SPIRO) and [3H]N-n-propylnorapomorphine ([3H]NPA), a dopamine antagonist and agonist, respectively, were found to bind stereospecifically to bovine intermediate lobe pituitary membranes. The specific binding was saturable ([3H]SPIRO maximum number of binding sites, 11.2 pmol/g tissue; [3H]NPA maximum number of binding sites, 5.0 pmol/g tissue) and of high affinity affinity ([3H]SPIRO dissociation constant, 0.17 nM; [3H]NPA dissociation constant, 0.35 nM). The rank order of catecholamines, phenothiazines, and related drugs in competing for [3H]SPIRO and [3H]NPA binding is consistent with interactions at a dopamine receptor. Guanine nucleotides were found to selectively decrease agonist but not antagonist affinities for these binding sites. With the addition of 0.1 mM GTP, the ability of agonists to displace [3H]SPIRO binding is decreased 5- to 7-fold, while the dissociation constant for [3H]NPA is increased to 0.8 nM.
This article has been cited by other articles:
![]() |
R. Hnasko, S. Khurana, N. Shackleford, R. Steinmetz, M. J. Low, and N. Ben-Jonathan Two Distinct Pituitary Cell Lines from Mouse Intermediate Lobe Tumors: A Cell that Produces Prolactin-Regulating Factor and a Melanotroph Endocrinology, December 1, 1997; 138(12): 5589 - 5596. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |